USP30 and breast cancer: One such model includes nine metabolism-related lncRNAs—SIRLNT, SIAH2-AS1, MIR205HG, USP30-AS1, MIR200CHG, TFAP2A-AS1, AP005131.2, AL031316.1, and C6orf99—which shows potential for improving predictive accuracy and enabling personalized treatment for BC patients.